Buy Checkpoint Therapeutics Stock | CKPT Stock Price & Latest News | Public.com
CKPT

Checkpoint Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Checkpoint Therapeutics (CKPT) stock trends here

    About CKPT

    Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302....Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.03
    -0.06
    -0.09
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.09

    Actual EPS
    Q1 2021

    Stats

    Market Cap$224,69M
    Volume1,85M
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$5.38
    1 Year Low$1.05
    Open$2.89
    High$3.38
    Low$2.63

    Buy any stock with any amount of money.

    Download the App
    Download the app